Human adipose beiging in response to cold and mirabegron
Adult
Male
2. Zero hunger
0301 basic medicine
Biopsy
Subcutaneous Fat
Membrane Proteins
Adrenergic beta-3 Receptor Agonists
Thermogenesis
Adipose Tissue, Beige
Middle Aged
Lipid Metabolism
Cold Temperature
Thiazoles
03 medical and health sciences
Humans
Acetanilides
Female
Obesity
Energy Metabolism
Uncoupling Protein 1
DOI:
10.1172/jci.insight.121510
Publication Date:
2018-08-08T15:01:03Z
AUTHORS (14)
ABSTRACT
The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.Cold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.Clinicaltrials.gov NCT02596776, NCT02919176.NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (61)
CITATIONS (153)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....